Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the CHMP4B gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →The limited documentation surrounding cataract 31 multiple types can be frustrating. This condition affects a small number of individuals, making systematic clinical studies challenging. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand its implications. This means that while information may be scarce, there is ongoing research that could shed more light on the condition.
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Currently, there is one active clinical trial related to cataract 31 multiple types. Participating in clinical trials can provide access to cutting-edge treatments and contribute to the understanding of the condition. For more information, you can explore the active trial at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2031%20multiple%20types.
Actionable guidance for navigating care for cataract 31 multiple types
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding cataract 31 multiple types can be frustrating. This condition affects a small number of individuals, making systematic clinical studies challenging. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand its implications. This means that while information may be scarce, there is ongoing research that could shed more light on the condition.
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Currently, there is one active clinical trial related to cataract 31 multiple types. Participating in clinical trials can provide access to cutting-edge treatments and contribute to the understanding of the condition. For more information, you can explore the active trial at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2031%20multiple%20types.
Actionable guidance for navigating care for cataract 31 multiple types
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The limited documentation surrounding cataract 31 multiple types can be frustrating. This condition affects a small number of individuals, making systematic clinical studies challenging. Additionally, the genetic basis was only recently identified, and ongoing clinical characterization is necessary to fully understand its implications. This means that while information may be scarce, there is ongoing research that could shed more light on the condition.
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Currently, there is one active clinical trial related to cataract 31 multiple types. Participating in clinical trials can provide access to cutting-edge treatments and contribute to the understanding of the condition. For more information, you can explore the active trial at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2031%20multiple%20types.
Actionable guidance for navigating care for cataract 31 multiple types
To navigate your care, consider consulting with an ophthalmologist who specializes in genetic eye disorders, as they can provide tailored management strategies. It may also be beneficial to seek genetic counseling to understand the implications of the CHMP4B mutation for you and your family. While there are no specific patient organizations identified for this condition, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can offer support and information. Additionally, participating in clinical trials could provide further insights into your condition.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.